Analysis of segmental duplications, mouse genome synteny and recurrent cancer-associated amplicons in human chromosome 6p21-p12

Cytogenetic and Genome Research

Volumn 128, Issue 4, 2010, Pages 199-213

  Martin, J W ^a   Yoshimoto, M ^a   Ludkovski, O ^b   Thorner, P S ^c   Zielenska, M ^c   Squire, J A ^a,d   Nuin, P A S ^a,d  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Queen's Cancer Research Institute   (Canada)

Author keywords

Bioinformatics; Mouse human synteny; Oncogenesis; Segmental duplications

Indexed keywords

AMPLICON; ARTICLE; CHROMOSOME 6P; CHROMOSOME DUPLICATION; CHROMOSOME REARRANGEMENT; COMPUTER MODEL; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA RECOMBINATION; DNA REPAIR; GENE AMPLIFICATION; GENE FREQUENCY; GENE INSERTION SEQUENCE; GENE LOCATION; GENE TARGETING; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC DATABASE; GENOME ANALYSIS; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; RECURRENT CANCER; SYNTENY;

ANIMALS; BONE NEOPLASMS; CELL DIFFERENTIATION; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; GENE AMPLIFICATION; GENE REARRANGEMENT; GENOME; HUMANS; MICE; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OSTEOBLASTS; OSTEOSARCOMA; RECURRENCE; SEGMENTAL DUPLICATIONS, GENOMIC; SHORT INTERSPERSED NUCLEOTIDE ELEMENTS; SYNTENY;

EID: 77953426747     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000308353     Document Type: Article

References (98)

1. Andre F, Job B, Dessen P, Tordai A, et al: Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 15: 441-451 (2009).
2. Andrieux J, Richebourg S, Duban-Bedu B, Petit F, et al: Characterization by array-CGH of an interstitial de novo tandem 6p21.2p22.1 duplication in a boy with epilepsy and developmental delay. Eur J Med Genet 51: 373-381 (2008).
3. Armengol L, Pujana MA, Cheung J, Scherer SW, et al: Enrichment of segmental duplications in regions of breaks of synteny between the human and mouse genomes suggest their involvement in evolutionary rearrangements. Hum Mol Genet 12: 2201-2208 (2003).
4. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR: Molecular cytogenetic analysis of basal cell carcinoma DNA using comparative genomic hybridization. J Invest Dermatol 117: 683-686 (2001).
5. Atiye J, Wolf M, Kaur S, Monni O, et al: Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 42: 158-163 (2005).
6. Ausubel FBR, Kingston R, Moore D, Seidman J, Smith J, Sturhl K: Current Protocols in Molecular Biology. (Wiley, New York 2002).
7. Bailey JA, Gu Z, Clark RA, Reinert K, et al: Recent segmental duplications in the human genome. Science 297: 1003-1007 (2002).
8. Bailey JA, Church DM, Ventura M, Rocchi M, et al: Analysis of segmental duplications and genome assembly in the mouse. Genome Res 14: 789-801 (2004).
9. Baudis M: Online database and bioinformatics toolbox to support data mining in cancer cytogenetics. Biotechniques 40: 269-270, 272 (2006).
10. Baudis M: Genomic imbalances in 5918 malignant epithelial tumors: an explorative metaanalysis of chromosomal CGH data. BMC Cancer 7: 226 (2007).
11. Baudis M, Cleary ML: Progenetixnet: an online repository for molecular cytogenetic aberration data. Bioinformatics 17: 1228-1229 (2001).
12. Berman SD, Calo E, Landman AS, Danielian PS, et al: Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci USA 105: 11851-11856 (2008a).
13. Berman SD, Yuan TL, Miller ES, Lee EY, et al: The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone development. Mol Cancer Res 6: 1440-1451 (2008b).
14. Bernstein HS, Coughlin SR: A mammalian homolog of fission yeast Cdc5 regulates G2 progression and mitotic entry. J Biol Chem 273: 4666-4671 (1998).
15. Bi W, Yan J, Stankiewicz P, Park SS, et al: Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse. Genome Res 12: 713-728 (2002).
16. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, et al: Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11: 7012-7022 (2005).
17. Bonaldi L, Midena E, Filippi B, Tebaldi E, et al: FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol 134: 1123-1127 (2008).
18. Bowles E, Corson TW, Bayani J, Squire JA, et al: Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosomes Cancer 46: 118-129 (2007).
19. Branzei D, Foiani M: The DNA damage response during DNA replication. Curr Opin Cell Biol 17: 568-575 (2005).
20. Chanudet E, Ye H, Ferry J, Bacon CM, et al: A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol 217: 420-430 (2009).
21. Cheung J, Estivill X, Khaja R, MacDonald JR, et al: Genome-wide detection of segmental duplications and potential assembly errors in the human genome sequence. Genome Biol 4:R25 (2003).
22. Chiang DY, Villanueva A, Hoshida Y, Peix J, et al: Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 68: 6779-6788 (2008).
23. Chochi Y, Kawauchi S, Nakao M, Furuya T, et al: A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study. J Pathol 217: 677-684 (2009).
24. Cordaux R, Baxter MA: The impact of retrotransposons on human genome evolution. Nature Rev Genet 10: 691-703 (2009).
25. DeSilva U, Elnitski L, Idol JR, Doyle JL, et al: Generation and comparative analysis of approximately 33 Mb of mouse genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in Williams syndrome. Genome Res 12: 3-15 (2002).
26. Dominguez MG, Wong-Ley LE, Rivera H, Vasquez AI, et al: Pure partial trisomy 6p due to a familial insertion (16; 6)(p12;p21.2p23). Ann Genet 46: 45-48 (2003).
27. Ehlers JP, Worley L, Onken MD, Harbour JW: Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 14: 115-122 (2008).
28. Eichler EE: Masquerading repeats: paralogous pitfalls of the human genome. Genome Res 8: 758-762 (1998).
29. Gimelli G, Pujana MA, Patricelli MG, Russo S, et al: Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions. Hum Mol Genet 12: 849-858 (2003).
30. Gorringe KL, Boussioutas A, Bowtell DD: Novel regions of chromosomal amplification at 6p21, 5p13 and 12q14 in gastric cancer identified by array comparative genomic hybridization. Genes Chromosomes Cancer 42: 247-259 (2005).
31. Graub R, Lancero H, Pedersen A, Chu M, et al: Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processing. Cell Cycle 7: 1795-1803 (2008).
32. Gu W, Zhang F, Lupski JR: Mechanisms for human genomic rearrangements. Pathogenetics 1: 4 (2008).
33. Gutierrez GM, Kong E, Sabbagh Y, Brown NE, et al: Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1 -/-mice. Proc Natl Acad Sci USA 105: 18402-18407 (2008).
34. Hastings PJ, Ira G, Lupski JR: A microhomologymediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327 (2009).
35. Heidenblad M, Lindgren D, Jonson T, Liedberg F, et al: Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors. BMC Med Genomics 1: 3 (2008).
36. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, et al: Detection of large-scale variation in the human genome. Nat Genet 36: 949-951 (2004).
37. Ji Y, Eichler EE, Schwartz S, Nicholls RD: Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 10: 597-610 (2000).
38. Jonsson G, Staaf J, Olsson E, Heidenblad M, et al: High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 46: 543-558 (2007).
39. Karolchik D, Kuhn RM, Baertsch R, Barber GP, et al: The UCSC Genome Browser Database: 2008 update. Nucleic Acids Res 36:D773-D779 (2008).
40. Kasugai Y, Tagawa H, Kameoka Y, Morishima Y, et al: Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma. Clin Cancer Res 11: 8265-8272 (2005).
41. Kolomietz E, Meyn MS, Pandita A, Squire JA: The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35: 97-112 (2002).
42. Koszul R, Fischer G: A prominent role for segmental duplications in modeling eukaryotic genomes. CR Biol 332: 254-266 (2009).
43. Krzywinski MI, Schein JE, Birol I, Connors J, et al: Circos: an information aesthetic for comparative genomics. Genome Res DOI: 101101/gr092759109 (2009).
44. Kubler K, Arndt PF, Wardelmann E, Landwehr C, et al: Genetic alterations of HLA-class II in ovarian cancer. Int J Cancer 123: 1350-1356 (2008).
45. Lau CC, Harris CP, Lu XY, Perlaky L, et al: Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 39: 11-21 (2004).
46. Lim G, Karaskova J, Beheshti B, Vukovic B, et al: An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification microdeletions and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma. Genes Chromosomes Cancer 42: 392-403 (2005).
47. Locke DP, Archidiacono N, Misceo D, Cardone MF, et al: Refinement of a chimpanzee pericentric inversion breakpoint to a segmental du pli cation cluster. Genome Biol 4:R50 (2003a).
48. Locke DP, Segraves R, Carbone L, Archidiacono N, et al: Large-scale variation among human and great ape genomes determined by array comparative genomic hybridization. Genome Res 13: 347-357 (2003b).
49. Lu XY, Lu Y, Zhao YJ, Jaeweon K, et al: Cell cycle regulator gene CDC5L a potential target for 6p12-p21 amplicon in osteosarcoma. Mol Cancer Res 6: 937-946 (2008).
50. Man TK, Lu XY, Jaeweon K, Perlaky L, et al: Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 4: 45 (2004).
51. Maser RS, Choudhury B, Campbell PJ, Feng B, et al: Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 447: 966-971 (2007).
52. Mehan MR, Freimer NB, Ophoff RA: A genomewide survey of segmental duplications that mediate common human genetic variation of chromosomal architecture. Hum Genomics 1: 335-344 (2004).
53. Mehan MR, Almonte M, Slaten E, Freimer NB, et al: Analysis of segmental duplications reveals a distinct pattern of continuation-ofsynteny between human and mouse genomes. Hum Genet 121: 93-100 (2007).
54. Mensink HW, Kilic E, Vaarwater J, Douben H, et al: Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet 181: 108-111 (2008).
55. Mungall AJ, Palmer SA, Sims SK, Edwards CA, et al: The DNA sequence and analysis of human chromosome 6. Nature 425: 805-811 (2003).
56. Namiki T, Yanagawa S, Izumo T, Ishikawa M, et al: Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Cancer Genet Cytogenet 157: 1-11 (2005).
57. Nathan SS, Pereira BP, Zhou YF, Gupta A, et al: Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma. Mol Biol Rep 36: 153-158 (2009).
58. Ng D, Mowrey P, Ragoussis J, Mirza G, et al: Molecularly defined interstitial tandem duplication 6p case with mild manifestations. Am J Med Genet 103: 320-325 (2001).
59. Nowee ME, Snijders AM, Rockx DA, de Wit RM, et al: DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol 213: 46-55 (2007).
60. Ottaviani D, Lever E, Mitter R, Jones T, et al: Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex. Genome Res 18: 1778-1786 (2008).
61. Ozaki T, Schaefer KL, Wai D, Buerger H, et al: Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. Int J Cancer 102: 355-365 (2002).
62. Ozaki T, Neumann T, Wai D, Schafer KL, et al: Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping. Cancer Genet Cytogenet 140: 145-152 (2003).
63. Pace JK 2nd, Sen SK, Batzer MA, Feschotte C: Repair-mediated duplication by capture of proximal chromosomal DNA has shaped vertebrate genome evolution. PLoS Genet 5:e1000469 (2009).
64. Partheen K, Levan K, Osterberg L, Helou K, et al: Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival surgical outcome and substage. Genes Chromosomes Cancer 40: 342-348 (2004).
65. Paulson KG, Lemos BD, Feng B, Jaimes N, et al: Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol 129: 1547-1555 (2009).
66. Pevzner P, Tesler G: Genome rearrangements in mammalian evolution: lessons from human and mouse genomes. Genome Res 13: 37-45 (2003).
67. Ruiz-Herrera A, Robinson TJ: Evolutionary plasticity and cancer breakpoints in human chromosome 3. Bioessays 30: 1126-1137 (2008).
68. Sadikovic B, Thorner P, Chilton-MacNeill S, Martin JW, et al: Expression analysis of genes associated with human osteosarcoma tumors show correlation of RUNX2 overexpression with poor response to chemotherapy. BMC Cancer (in press).
69. Sadikovic B, Yoshimoto M, Chilton-MacNeill S, Thorner P, et al: Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol Genet 18: 1962-1975 (2009).
70. Salvesen HB, Carter SL, Mannelqvist M, Dutt A, et al: Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci USA 106: 4834-4839 (2009).
71. Samonte RV, Eichler EE: Segmental duplications and the evolution of the primate genome. Nat Rev Genet 3: 65-72 (2002).
72. Santos GC, Zielenska M, Prasad M, Squire JA: Chromosome 6p amplification and cancer progression. J Clin Pathol 60: 1-7 (2007).
73. Sastre-Garau X, Peter M, Avril MF, Laude H, et al: Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 218: 48-56 (2009).
74. Selvarajah S, Yoshimoto M, Ludkovski O, Park PC, et al: Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Cytogenet Genome Res 122: 5-15 (2008).
75. Seute A, Sinn HP, Schlenk RF, Emig R, et al: Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients. Int J Cancer 93: 80-84 (2001).
76. Shaw CJ, Lupski JR: Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 13:R57-R64 (2004).
77. Sinha AU, Meller J: Cinteny: flexible analysis and visualization of synteny and genome rearrangements in multiple organisms. BMC Bioinformatics 8: 82 (2007).
78. Squire J, Phillips RA, Boyce S, Godbout R, et al: Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques new densitometric methods and somatic cell hybridization. Hum Genet 66: 46-53 (1984).
79. Squire JA, Pei J, Marrano P, Beheshti B, et al: Highresolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 38: 215-225 (2003).
80. Stankiewicz P, Lupski JR: Genome architecture rearrangements and genomic disorders. Trends Genet 18: 74-82 (2002a).
81. Stankiewicz P, Lupski JR: Molecular-evolutionary mechanisms for genomic disorders. Curr Opin Genet Dev 12: 312-319 (2002b).
82. Strausberg RL, Greenhut SF, Grouse LH, Schaefer CF, et al: In silico analysis of cancer through the Cancer Genome Anatomy Project. Trends Cell Biol 11:S66-S71 (2001).
83. Tagawa H, Karnan S, Suzuki R, Matsuo K, et al: Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24: 1348-1358 (2005).
84. Takousis P, Johonnett P, Williamson J, Sasieni P, et al: Replication timing profile reflects the distinct functional and genomic features of the MHC class II region. Cell Cycle 6: 2393-2398 (2007).
85. Tanami H, Tsuda H, Okabe S, Iwai T, et al: Involvement of cyclin D3 in liver metastasis of colorectal cancer revealed by genome-wide copy-number analysis. Lab Invest 85: 1118-1129 (2005).
86. Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, et al: DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84: 114-121 (1999).
87. Thomas DM, Johnson SA, Sims NA, Trivett MK, et al: Terminal osteoblast differentiation mediated by runx2 and p27KIP1 is disrupted in osteosarcoma. J Cell Biol 167: 925-934 (2004).
88. Tomovska S, Richter J, Suess K, Wagner U, et al: Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer. Int J Oncol 18: 1239-1244 (2001).
89. Traherne JA: Human MHC architecture and evolution: implications for disease association studies. Int J Immunogenet 35: 179-192 (2008).
90. Valero MC, de Luis O, Cruces J, Perez Jurado LA: Fine-scale comparative mapping of the human 7q11.23 region and the orthologous region on mouse chromosome 5G: the lowcopy repeats that flank the Williams-Beuren syndrome deletion arose at breakpoint sites of an evolutionary inversion(s). Genomics 69: 1-13 (2000).
91. Ventura RA, Martin-Subero JI, Jones M, McParland J, et al: FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 8: 141-151 (2006).
92. Villa A, Gomez EG, Rodriguez L, Rastrollo RH, et al: Interstitial tandem duplication of 6p: a case with partial trisomy (6)(p12p21.3). Am J Med Genet 90: 369-375 (2000).
93. Walkley CR, Qudsi R, Sankaran VG, Perry JA, et al: Conditional mouse osteosarcoma dependent on p53 loss and potentiated by loss of Rb mimics the human disease Genes Dev 22: 1662-1676 (2008).
94. Waterston RH, Lander ES, Sulston JE: On the sequencing of the human genome. Proc Natl Acad Sci USA 99: 3712-3716 (2002a).
95. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, et al: Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562 (2002b).
96. Yoshimoto M, Cunha IW, Coudry RA, Fonseca FP, et al: FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. Br J Cancer 97: 678-685 (2007).
97. Zielenska M, Marrano P, Thorner P, Pei J, et al: High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue. Cytogenet Genome Res 107: 77-82 (2004).
98. Zimonjic DB, Ullmannova-Benson V, Factor VM, Thorgeirsson SS, et al: Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease. Cancer Genet Cytogenet 191: 17-26 (2009).